by Jessica | Oct 17, 2021
Plexium has landed $28 million in Series A financing to launch a proprietary platform that can identify novel therapeutics that can modulate protein degradation to treat cancer and neurodegenerative diseases. The platform technology, dubbed DELPhe, takes advantage of...
by Jessica | Nov 14, 2019
Merck has acquired Calporta Therapeutics, Inc., a San Diego biotech focused on developing drugs that support lysosome function, which could combat diseases (including Alzheimer’s and Parkinson’s disease) linked to the toxic buildup of certain protein molecules. The...
by Jessica | Nov 14, 2019
Artificial intelligence-enabled drug discovery startup X-37, LLC, announced it has closed $14.5 million in Series A funding to expand its drug development programs and advance identified drug leads through laboratory and preclinical testing, with the goal of starting...
